386 related articles for article (PubMed ID: 23485507)
1. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.
Bjurlin MA; Carter HB; Schellhammer P; Cookson MS; Gomella LG; Troyer D; Wheeler TM; Schlossberg S; Penson DF; Taneja SS
J Urol; 2013 Jun; 189(6):2039-46. PubMed ID: 23485507
[TBL] [Abstract][Full Text] [Related]
2. Standards for prostate biopsy.
Bjurlin MA; Taneja SS
Curr Opin Urol; 2014 Mar; 24(2):155-61. PubMed ID: 24451092
[TBL] [Abstract][Full Text] [Related]
3. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
[TBL] [Abstract][Full Text] [Related]
4. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.
Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Cookson MS
BJU Int; 2001 Nov; 88(7):722-6. PubMed ID: 11890243
[TBL] [Abstract][Full Text] [Related]
6. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
Villa L; Capitanio U; Briganti A; Abdollah F; Suardi N; Salonia A; Gallina A; Freschi M; Russo A; Castiglione F; Bianchi M; Rigatti P; Montorsi F; Scattoni V
J Urol; 2013 Mar; 189(3):854-9. PubMed ID: 23022004
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.
Ishizaki F; Hara N; Koike H; Kawaguchi M; Tadokoro A; Takizawa I; Nishiyama T; Takahashi K; Hohenfellner R
Diagn Pathol; 2012 Jun; 7():68. PubMed ID: 22697234
[TBL] [Abstract][Full Text] [Related]
8. Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.
Bjurlin MA; Meng X; Le Nobin J; Wysock JS; Lepor H; Rosenkrantz AB; Taneja SS
J Urol; 2014 Sep; 192(3):648-58. PubMed ID: 24769030
[TBL] [Abstract][Full Text] [Related]
9. Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens.
Iremashvili V; Pelaez L; Jorda M; Manoharan M; Arianayagam M; Rosenberg DL; Soloway MS
Urology; 2012 Jan; 79(1):37-42. PubMed ID: 22055691
[TBL] [Abstract][Full Text] [Related]
10. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.
Ukimura O; Coleman JA; de la Taille A; Emberton M; Epstein JI; Freedland SJ; Giannarini G; Kibel AS; Montironi R; Ploussard G; Roobol MJ; Scattoni V; Jones JS
Eur Urol; 2013 Feb; 63(2):214-30. PubMed ID: 23021971
[TBL] [Abstract][Full Text] [Related]
11. How accurate is our clinical prediction of "minimal prostate cancer"?
Leibovici D; Shikanov S; Gofrit ON; Zagaja GP; Shilo Y; Shalhav AL
Isr Med Assoc J; 2013 Jul; 15(7):359-63. PubMed ID: 23943981
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer polar localization on core biopsy predicts pathologic stage.
Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
[TBL] [Abstract][Full Text] [Related]
13. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy.
Ficarra V; Novella G; Novara G; Galfano A; Pea M; Martignoni G; Artibani W
Eur Urol; 2005 Dec; 48(6):932-7. PubMed ID: 16202510
[TBL] [Abstract][Full Text] [Related]
14. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
Philip J; Hanchanale V; Foster CS; Javlé P
BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
[TBL] [Abstract][Full Text] [Related]
15. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
[TBL] [Abstract][Full Text] [Related]
16. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer.
Taylor JA; Gancarczyk KJ; Fant GV; Mcleod DG
Urology; 2002 Nov; 60(5):841-5. PubMed ID: 12429312
[TBL] [Abstract][Full Text] [Related]
17. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
20. Length of prostate biopsy cores: does it impact cancer detection?
Fiset PO; Aprikian A; Brimo F
Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]